According to a 2017 article, doctors usually administer testosterone through injections or transdermally via a person’s skin. Alternatively, they may choose to do so if they are transgender and opt to take supplements as part of their transition process. Novel agents and future research on safety and efficacy will hopefully provide more options and a brighter future for our patients. The studies reviewed here show efficacy and safety, but the effects of long term use remain to be elucidated. The ability to restore testosterone rather than replace it may change the way the aging male will pursue his health in the golden years. As our ability to better diagnose and recognize this complex disease process improves, clinicians will understandably seek to improve the safety and efficacy of the existing treatment modalities.
The individual can then make a better decision about the potential benefits they would have and weigh them against the risks. People may wish to supplement their testosterone to counteract these natural effects of aging. A person can only purchase testosterone with a valid prescription from a healthcare professional. There are various ways a person can take testosterone, such as subdermally, by injecting the hormone, or orally. Anabolic steroids contain testosterone that is either natural or synthetic.
Other meta-analyses that have included observational studies with less stringent inclusion criteria have demonstrated variable improvements in fasting glucose, insulin resistance, and HbA1c levels.138, 325, 326 Given the link between LTBF and morbidity and mortality in older men, evaluating bone density is an important step in the assessment of patients with testosterone deficiency. In trials, patients with low testosterone have demonstrated statistically significant improvements in erectile function, anemia, BMD, lean body mass, and depressive symptoms. If the Hct exceeds 50%, clinicians should consider withholding testosterone therapy until the etiology of the high Hct is explained.187 While on testosterone therapy, a Hct ≥54% warrants intervention. Another multi-center study compared the effectiveness and risks of transdermal and IM testosterone in 66 men aged years old. After 180 days of treatment, only 1 patient in the 50mg gel arm, 3 patients in the 100mg gel arm, and no patients in the testosterone patch arm were found to have gynecomastia. Hypergonadotropic hypogonadism, which is not a contraindication to begin testosterone therapy, can result from a number of conditions, including congenital abnormalities (KS being the most common), iatrogenic causes (e.g., bilateral orchiectomy, testicular radiation, chemotherapy), testicular trauma, infection, or autoimmune damage.
In the IM testosterone group, there were no new cases of gynecomastia, and one patient with pre-existing gynecomastia had gynecomastia resolution.181 An evaluation for a prolactinoma in such patients is imperative because these benign tumors can be effectively managed using medications, such as bromocriptine or carbergoline. However, the literature at this time fails to define the LH level below which such adjunctive testing is warranted. The validated instruments include ADAM, Quantitative ADAM, Aging Male Survey (AMS), MMAS, and the ANDROTEST.10, 166, 167 Specificities and sensitivities vary greatly amongst these tests making them ill-suited for screening or for use as a surrogate for testosterone laboratory testing.
The goals of this document are to (i) guide clinicians in how to assess patients for testosterone deficiency and manage them with testosterone products, and (ii) educate clinicians in key areas of testosterone in which many clinicians are deficient (e.g., interpreting the testosterone literature, understanding testosterone laboratory testing). The explosion in the use of testosterone in the past decade is multifactorial in its etiology, including the increased use of direct-to-consumer advertising, which has resulted in greater patient knowledge and demand; relaxation of the indications for testosterone prescribing by clinicians; and the establishment of clinical care centers devoted to men's health, testosterone treatment, and anti-aging strategies. Clinicians should discuss the risk of transference with patients using testosterone gels/creams. Exogenous testosterone therapy should not be prescribed to men who are currently trying to conceive. All men with testosterone deficiency should be counseled regarding lifestyle modifications as a treatment strategy. Clinicians should inform testosterone deficient patients that low testosterone is a risk factor for cardiovascular disease.
A synthetic testosterone for women is only licensed in Australia. Most of the testosterone is produced in the ovaries. Women and people assigned female at birth do produce testosterone as well as estrogen, though the amounts of testosterone are much smaller than those produced by men. Testosterone replacement therapy for women It's natural for testosterone to decline as you age and not necessarily a reason for TRT.
Testosterone therapy can be considered in those men who have undergone radical prostatectomy (RP) with favorable pathology (e.g., negative margins, negative seminal vesicles, negative lymph nodes), and who have undetectable PSA postoperatively. If the testosterone concentration is increased further, rather than further proliferation, the cells reduce their rate of proliferation.343, 344 This phenomenon is known as the bipolar testosterone concept. From a clinical standpoint, it dictates that there is a testosterone threshold beyond which prostate cells (benign or malignant) cease responding. The other men in the study already had metastatic disease at the time of testosterone initiation.

Gender: Female

Social links